Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers February 12, 2016
Pharmacy Choice - News - Generic Drugs - February 12, 2016

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 25 of 71     Next >>     Go To Page:

2/12/16 - 11 companies approved for sale of latest hepatitis C drug: Saira
Minister of State for Health Services, Regulations and Coordination Saira Afzal Tarar Thursday said that Drug Regulatory Authority of Pakistan had approved 11 new companies for sale of generic version of a new miracle drug Sofosbuvir, the latest therapy available in the world for hepatitis C. Saira Tarar said prevalence of hepatitis C in Pakistan w
2/12/16 - 11 COMPANIES APPROVED FOR SALE OF LATEST HEPATITIS C DRUG: SAIRA [Pakistan Observer]
Minister of State for Health Services, Regulations and Coordination Saira Afzal Tarar Thursday said that Drug Regulatory Authority of Pakistan had approved 11 new companies for sale of generic version of a new miracle drug Sofosbuvir, the latest therapy available in the world for hepatitis C. Addressing a press conference here Thursday, she said DR
2/12/16 - 9 firms allowed to sell cheaper hepatitis C pills
The Drug Regulatory Authority of Pakistan has authorised 11 pharmaceutical companies for sale of generic version of new drug Sofosbuvir which will be available for Rs5, 868 for Hepatitis C patients in the country. Minister of National Health Services, Regulation and Coordination Saira Afzal Tarar said this while addressing a press conference here o
2/12/16 - Azp 241-17 / 16. purchase with the delivery of cancer drugs, generic drugs, antibiotics, infusion solutions for hospital pharmacies holy cross cancer... [TendersInfo (India)]
Azp 241-17/ 16. purchase with the delivery of cancer drugs, generic drugs, antibiotics, infusion solutions for hospital pharmacies holy cross cancer center in kielce. Contract notice: Azp 241-17/ 16. purchase with the delivery of cancer drugs, generic drugs, antibiotics, infusion solutions for hospital pharmacies holy cross cancer center in kielce.
2/12/16 - BIODELIVERY SCIENCES INTERNATIONAL INC FILES (8-K) Disclosing Other Events
On February 8, 2016, BioDelivery Sciences International, Inc. received a purported notice relating to a paragraph IV certification from Actavis Laboratories UT, Inc. seeking to find invalid three Orange Book listed patents of the Company relating specifically to the Company's BUNAVAIL buccal film for the maintenance treatment of opioid dependenc
2/12/16 - BRIEF: British regulators fine GSK $54.5M [The Philadelphia Inquirer]
Feb. 12 GlaxoSmithKline, with major U.S. operations in the Philadelphia area, was fined $54.5 million, or 37.6 million pounds, Friday by a British competition authority for allegedly preventing less-expensive generic versions of its anti-depressant drug Seroxat from entering the market. GlaxoSmithKline has commercial operations primarily for vacc
2/12/16 - CMA fines pharma companies 45 million pounds
The CMA has found that these payments and other value transfers were aimed at delaying the potential entry of generic competitors into the UK market for paroxetine. In 2001, a number of pharmaceutical companies including Generics Limited and Alpharma Limited were taking steps to enter the UK market for paroxetine with a generic version.
2/12/16 - CMA fines pharma companies 45 million
The CMA has found that these payments and other value transfers were aimed at delaying the potential entry of generic competitors into the UK market for paroxetine. In 2001, a number of pharmaceutical companies- including Generics Limited and Alpharma Limited- were taking steps to enter the UK market for paroxetine with a generic version.
2/12/16 - Findings from F. Hoffmann-La Roche Yields New Findings on Cefotaxime (Pharmaceutical quality of eight generics of ceftriaxone preparation for...
According to news reporting originating in Basel, Switzerland, by NewsRx journalists, research stated, "To compare the pharmaceutical quality of original and generic ceftriaxone sodium preparations for injection produced in Eastern Asia. Generics produced in China, India, and Indonesia were sampled in China and Myanmar within their expiration dates
2/12/16 - Glaxo fined 37.6m for 'illegal behaviour' over Seroxat deals
GlaxoSmithKline has been fined 37.6 m by Britain s competition authority for illegal behaviour in relation to its antidepressant Seroxat that resulted in higher costs for the NHS. The Competition& Markets Authority said the pharmaceutical firm had paid generic drugmakers more than 50 m between 2001 and 2004 in return for them delaying
2/12/16 - Glaxo fined 37.6m for anti-competitive behaviour with Seroxat
GlaxoSmithKline has been fined 37.6 m by Britain s competition authority for anti-competitive behaviour in relation to its antidepressant Seroxat. The Competition& Markets Authority said the pharmaceutical firm had paid generic drugmakers more than 50 m between 2001 and 2004 in return for them delaying the launch of cheaper versions of the..
2/12/16 - Global Biologics and Biosimilars Market Scenario to 2021 with Volume, Value and Sale Price Analysis by Regions, Types and Applications Available at ReportsWeb.com
The Global Biologics and Biosimilars Industry 2016 Market Research Report is a professional and in-depth study on the current state of the Biologics and Biosimilars industry. Global Biologics and Biosimilars market report provides a basic overview of the industry including definitions, classifications, applications and industry chain structure.
2/12/16 - IGI Securities Limited - Investor Kit
Drug Regulatory Authority of Pakistan has approved 11 new companies for sale of generic version of a new miracle drug namely Sofosbuvir, which is the latest therapy available in the world for Hepatitis C. Minister of State for National Health Services and Regulations Saira Afzal Tarar said this on Thursday while addressing a press conference here i
2/12/16 - IGI Securities Limited - Investor Kit [Pakistan Press International]
Drug Regulatory Authority of Pakistan has approved 11 new companies for sale of generic version of a new miracle drug namely Sofosbuvir, which is the latest therapy available in the world for Hepatitis C. Minister of State for National Health Services and Regulations Saira Afzal Tarar said this on Thursday while addressing a press conference here i
2/12/16 - Registration of generic version of new molecule, a breakthrough treatment for Hepatitis-C: Saira
Minister of State, Saira Afzal Tarar said that Drug Regulatory Authority of Pakistan has been encouraging manufacturers to produce generic drugs in the country to ensure availability of safe, efficacious and quality drugs at an affordable price to the patients. Siara Afzal Tarar said that it is pertinent to mention that prevalence of Hepatitis C in
2/12/16 - Sandoz Acquires Pfizer's Biosimilar Infliximab In EEA
BASEL- Sandoz, a Novartis company, announced that it has acquired from Pfizer the rights for the development and commercialization of PF-06438179 in the 28 countries that form the European Economic Area. As per the terms of the deal, Sandoz plans to complete the clinical study program and submit the biosimilar infliximab to the European Medicines A
2/12/16 - Sandoz Acquires Rights of Biosimilar Infliximab from Pfizer
Sandoz International GmbH, a generic pharmaceutical company and a division of Novartis AG, has acquired the rights of PF-06438179, from Pfizer Inc., a pharmaceutical company, for the development and commercialization in the 28 countries that form the European Economic Area. Sandoz acquired the rights to infliximab, following Pfizer's commitments to
2/12/16 - SANDOZ ADVANCES ITS BIOSIMILARS PROGRAM WITH EMA ACCEPTANCE OF REGULATORY SUBMISSION FOR BIOSIMILAR PEGFILGRASTIM
Release date- 11022016- Sandoz, a Novartis company and the global leader in biosimilars, announced today that the European Medicines Agency has accepted their Marketing Authorization Application for its biosimilar to Amgen's EU-licensed Neulasta*- a long-acting recombinant human granulocyte colony-stimulating factor. Commenting on today's milestone
2/12/16 - U.K.'s CMA Fines Pharma Companies GBP 45 Mln
The CMA has found that these payments and other value transfers were aimed at delaying the potential entry of generic competitors into the UK market for paroxetine. In respect of Alpharma's infringement, total fines of 1.54 million pounds have been imposed on Actavis UK Limited, Xellia Pharmaceuticals ApS and Alpharma LLC (formerly Zoetis Products
2/12/16 - UK competition authorities fine GSK $54.5 million
Britain's competition authority has fined drugmaker GlaxoSmithKline plc 37.6 million pounds for stalling the potential entry of generic competitors of an anti-depressant drug Seroxat into the marketplace. "Today's decision sends out a strong message that we will tackle illegal behavior that is designed to stifle competition at the expense of...
2/12/16 - Vensun Pharmaceuticals, Inc. Appoints Joan Janulis as the SVP of Regulatory Affairs and Compliance
Vensun Pharmaceuticals, Inc., a privately held generic pharmaceutical company, today announced the appointment of Joan Janulis as the Senior Vice President of Regulatory Affairs and Compliance. Ms. Janulis is a highly experienced pharmaceutical executive with extensive knowledge of U.S. Food and Drug Administration regulations, guidance and best...
2/11/16 - CIT Serves as Lead Arranger in $190 Million Financing of Vertical/Trigen Holdings Combination with Osmotica
CIT Group Inc., cit.com, a leading provider of commercial lending and leasing services, today announced that CIT Healthcare Finance served as Lead Arranger for a $190 million senior secured credit facility to help finance the combination of Vertical/Trigen Holdings, LLC with Osmotica Holdings Corp Limited, a specialty pharmaceutical company with a.
2/11/16 - Drug Regulatory Authority of Pakistan encouraging manufacturers to produce generic drugs to ensure availability of safe, efficacious and quality drugs at affordable price to patients: Minister - Press Note issued by Press Information Department
Minister of State, Saira Afzal Tarar said that Drug Regulatory Authority of Pakistan has been encouraging manufacturers to produce generic drugs in the country to ensure availability of safe, efficacious and quality drugs at an affordable price to the patients. Saira Afzal Tarar said that it is pertinent to mention that prevalence of Hepatitis C in
2/11/16 - Drug Regulatory Authority of Pakistan encouraging manufacturers to produce generic drugs to ensure availability of safe, efficacious and quality... [Pakistan Press International]
Drug Regulatory Authority of Pakistan encouraging manufacturers to produce generic drugs to ensure availability of safe, efficacious and quality drugs at affordable price to patients: Minister- Press Note issued by Press Information Department. Minister of State, Saira Afzal Tarar said that Drug Regulatory Authority of Pakistan has been encouraging
2/11/16 - Drugmaker Mylan strikes $9.9 bn deal to acquire Meda [Big News Network (United Arab Emirates)]
LONDON Global branded and generic drugmaker Mylan NV has entered into a cash-and-stock deal to acquire specialty pharmaceutical company Meda AB for $9.9 billion including the Swedish company's net debt, ending a long pursuit to strike the deal. The deal comes three months after Mylan's failed hostile takeover of Perrigo Co., an Ireland- based drug
Articles(s): 1 - 25 of 71     Next >>     Go To Page:


© 2016 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

FEATURED CE LESSON

Men's Health in Older Adults: Benign Prostatic Hyperplasia and Erectile Dysfunction
This lesson is supported by:
RxSchool
Pharmacy Spanish
This lesson is supported by:
Hands on Spanish
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:
RxSchool

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...


Websites » RxCareerCenter.comRxSchool.comRxProHealth.comNursingJobSource.comNurseZone.comRN.com
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415